Moderna Tells Fed. Circ. US Must Face COVID Vax Patent Case
Moderna has urged the Federal Circuit to rule that Arbutus Biopharma must pursue its patent infringement claims over Moderna's COVID-19 vaccine against the U.S. government, saying a lower court ruling that...To view the full article, register now.
Already a subscriber? Click here to view full article